Zhejiang Cancer Hospital

This early safety study is testing whether cells from donated umbilical cord blood can help treat lung injury caused by radiation therapy for cancer. Researchers will give these cells to 10 patients whose lung damage hasn't improved with standard treatments. They'll monitor for s…

This study aims to understand why some premenopausal women with hormone-sensitive breast cancer stop taking their hormone-blocking therapy early. Researchers will follow 300 patients already receiving this standard treatment to see how well they stick with it and how treatment du…

This early-stage study is testing whether cells collected from donated umbilical cord blood are safe and can help heal the intestines of people who have long-term damage from past radiation therapy for cancer. It will involve 10 adults whose bowel symptoms haven't improved with s…

This study is testing whether adding a new drug called sac-TMT to a standard lung cancer pill, with or without brain radiation, can help control cancer that has spread to the brain after other similar pills have stopped working. It will involve about 45 adults with a specific typ…

This study is testing a two-part treatment for a specific type of rectal cancer. First, patients receive a short, intense course of radiation. Then, they receive an immunotherapy drug called AK112. The main goal is to see if this combination can completely eliminate the tumor, po…